References
- Martin W. R., Gorodetzky C. W. Cyclazocine, an adjunct in the treatment of narcotic addiction. Int. J. Addic. 1967; 2: 85–93
- Resnick R., Fink M., Freedman A. Cyclazocine treatment of opiate dependence: A progress report. Compr. Psychiatry 1971; 12: 491–501
- Zaks A., Jones T., Fink M., Freedman A. M. Naloxone treatment of opiate dependence: A progress report. J. Am. Med. Assoc. 1974; 215: 2108–2110
- O'Brien C. P., Chaddock B., Woody G., Greenstein R. Systematic extinction of narcotic drug use using narcotic antagonists. Proceedings of the Committee on Problems of Drug Dependence. 1974. National Academy of Sciences, Washington, DC, 216–222
- Martin W. R., Jasinski D., Manski P. Naltrexone, an antagonist for the treatment of heroin dependence. Arch. Gen. Psychiatry 1973; 28: 784–791
- Resnick R., Volavka J., Freedman A., Thomas M. Studies of EN-1638A (naltrexone): A new narcotic antagonist. Am. J. Psychiatry 1974; 131(6)646–650
- Martin W. R. Pathophysiology of narcotic addiction: Possible roles of protracted abstinence in relapse. Drug Abuse-Proceedings of the International Conference, C. J. D. Zarafonetis. Lea and Febiger, Philadelphia 1972; 153–159